🇺🇸 FDA
Patent

US 8071603

Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

granted A61PA61P1/16A61P3/04

Quick answer

US patent 8071603 (Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors) held by Xenon Pharmaceuticals Inc. expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/16, A61P3/04, A61P3/06, A61P3/08